Cardiovascular systems presents key LIBERTY 360° demographic data in late-breaking presentation at the 28th International Symposium on Endovascular Therapy
March 24, 2016In the News
LIBERTY 360° is a prospective, observational, multi-center post-market study that enrolled over 1,200 patients at 53 sites across the United States, including 500 patients in the Claudicant Rutherford Class 2-3 (R2-3) Arm, 600 in the CLI (critical limb ischemia) Rutherford Class 4-5 (R4-5) Arm and 100 in the CLI Rutherford Class 6 (R6) Arm. Authors on the abstract included Dr. William Gray, Main Line Health, Pennsylvania. See more from Spoke.